Description
INCORPORATING THE 2026 APPROVED SMALL BUSINESS SUBCONTRACTING PLAN INTO THE FSS CONTRACT.
Base award description: 65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-08-30+$0= $0
- Mod P000012025-02-20+$0= $0
- Mod P000022026-02-06+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-08-30 | +$0 | $0 | 65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD |
| Mod P00001· ADD SUBCONTRACTING PLAN | 2025-02-20 | +$0 | $0 | COMMERCIAL ITEMS (CHANGES) - SB SUBCONTRACTING PLAN |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-02-06 | +$0 | $0 | INCORPORATING THE 2026 APPROVED SMALL BUSINESS SUBCONTRACTING PLAN INTO THE FSS CONTRACT. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NK5QDVJBHMN7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126N0799 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $658,750 | FY2026 |
| 36C26326P0588 | NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $308,299 | FY2026 |
| 36C24126A0041 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24226N0439 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,481,077 | FY2026 |
| 36C24926N0423 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $471,122 | FY2026 |
| 36C24626N0476 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $421,178 | FY2026 |
Other recipients under 6550 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36F79726D0099 | ROCHE DIABETES CARE INC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79725D0206 | SEKISUI DIAGNOSTICS LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2025 |
| 36F79725D0119 | MEDMIRA LABORATORIES INC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2025 |
| 36F79725D0105 | US LABEL & RIBBON GROUP, INC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2025 |
| 36F79725D0085 | MHC MEDICAL PRODUCTS, LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36F79724D0201_3600 · retrieved 2026-09-26.